AIC
ACTU

AWM Investment Company’s Actuate Therapeutics ACTU Stock Holding History

AWM Investment Company’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-139,511
Closed -$1.04M – 103
2024
Q3 		$1.04M Buy
+139,511
New +$1.1M 0.13% 84

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NU
Northwestern University Evanston, Illinois $63.3M AUM 0.76% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLCM
KG&L Capital Management Saint Francisville, Louisiana $139M AUM 26.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

AWM Investment Company's ACTU Position: Q4 2024 in Review

AWM Investment Company sold out of Actuate Therapeutics (ACTU) in Q4 2024, closing a stake of 139,511 shares — an estimated $1.04M sold.

AWM Investment Company first reported a position in ACTU in Q3 2024 and held it in 1 quarter. The position peaked at $1.04M in Q3 2024. 19 funds tracked by Wall St. Rank hold ACTU as of Q4 2024.

  • AWM Investment Company reported no remaining Actuate Therapeutics position as of Q4 2024 after selling out during the quarter.
  • AWM Investment Company sold 139,511 Actuate Therapeutics shares in Q4 2024, an estimated $1.04M.
  • AWM Investment Company first reported a position in Actuate Therapeutics in Q3 2024 and held it in 1 quarter.
  • AWM Investment Company's Actuate Therapeutics position peaked at $1.04M in Q3 2024.
  • 19 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q4 2024.

Based on AWM Investment Company's 13F filing for Q4 2024, filed 18 Feb 2025.